r ADXS Stock Quote - Advaxis, Inc. Stock Price Today
TONIGHT! Join in as Kyle Dennis, 27 year-old,
self-made millionaire, reveals his newest trading strategy.
Days
Hours
Minutes
Seconds

Advaxis, Inc.
(NASDAQ : ADXS)

( )
ADXS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.00%79.541.2%$617.34m
AMGNAmgen Inc.
0.00%177.961.2%$579.57m
GILDGilead Sciences, Inc.
0.00%67.530.9%$547.73m
BIIBBiogen Inc.
0.00%284.411.2%$489.40m
REGNRegeneron Pharmaceuticals, Inc.
0.00%294.612.6%$305.85m
ILMNIllumina, Inc.
0.00%270.833.5%$228.12m
VRTXVertex Pharmaceuticals Incorporated
0.00%156.971.9%$223.27m
ALXNAlexion Pharmaceuticals, Inc.
0.00%117.142.0%$216.01m
AAgilent Technologies, Inc.
0.00%64.131.5%$205.67m
NKTRNektar Therapeutics
0.00%80.586.0%$188.74m
INCYIncyte Corporation
0.00%66.672.5%$152.87m
SRPTSarepta Therapeutics, Inc.
0.00%89.9916.6%$124.68m
BMRNBioMarin Pharmaceutical Inc.
0.00%88.284.4%$120.50m
EXASExact Sciences Corporation
0.00%52.8525.5%$108.34m
BLUEBluebird Bio, Inc.
0.00%187.0015.7%$96.24m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.